The Global Problem of Cervix Cancer (And How We Can Solve It)

George L. Maxwell, MD, is board certified in gynecologic oncology, obstetrics and gynecology. Dr. Maxwell’s interests are minimally invasive surgery techniques and ovarian cancer treatments. Recently, Dr. Maxwell attended and presented at a UN symposium dedicated to fighting cervical cancer in women around the world. Read Dr. Maxwell’s profile. On June 18, I was honored…

Read More

Prostate Cancer Is the Second Most Common Cancer in American Men

Dr. Aragon-Ching serves as the Clinical Program Director of Genitourinary Cancers within the Inova Dwight and Martha Schar Cancer Institute. Schedule an appointment or learn more about Dr. Aragon-Ching. Prostate Cancer Awareness Month Prostate cancer is the most common cancer, apart from skin cancer, that occurs among American men. In 2015 alone, a projected 220,000…

Read More

Preventing Melanoma: Should You Drink More Coffee and Hold Off on the Viagra?

Suraj Venna, MD, is board certified in dermatology. He is the founding director of the Inova Melanoma and Skin Cancer Center. Dr. Venna specializes in detecting and treating skin cancer. Dr. Venna is also chair for the 2015 American Society of Clinical Oncology Melanoma Education Committee, the largest international meeting of oncologists. Read Dr. Venna’s…

Read More

Hybrid Academic-Community Cancer Centers Take Shape, MedPage Today, August 31, 2015

“An alternative cancer center model has been emerging at a number of healthcare institutions around the country that offers patients local access to more and earlier-phase clinical trials and better care than they might receive in traditional community settings, a MedPage Today investigation found. These new hybrid centers also provide oncologists an opportunity to practice…

Read More

Jimmy Carter’s Rare Cancer Diagnosis

Suraj Venna, MD, is board certified in dermatology. He is the founding director of the Inova Melanoma and Skin Cancer Center. Dr. Venna specializes in detecting and treating skin cancer. Dr. Venna is also chair for the 2015 American Society of Clinical Oncology Melanoma Education Committee, the largest international meeting of oncologists. Read Dr. Venna’s…

Read More

The Future of Personalized Health at Inova

John Deeken, MD, is board certified in medical oncology. He specializes in treating patients with head and neck cancer. He is especially interested in using genomics to personalize cancer treatments and in developing targeted therapies. Dr. Deeken serves as associate director for Clinical Research for the Inova Dwight and Martha Schar Cancer Institute. In addition,…

Read More

Supplements: Proceed with Caution

Timothy L. Cannon, MD, is board certified in medical oncology, hematology and internal medicine. His specialty is managing gastrointestinal cancers. Dr. Cannon emphasizes personalized care for his patients and is interested in pharmacogenomics as well as using technology to improve patients’ access to care. Read Dr. Cannon’s profile. An employee once told me that she…

Read More

Pharmacogenomics: Personalized Medicine in Action

Dr. Cannon

Timothy L. Cannon, MD, is board certified in medical oncology, hematology and internal medicine. His specialty is managing gastrointestinal cancers. Dr. Cannon emphasizes personalized care for his patients and is interested in pharmacogenomics as well as using technology to improve patients’ access to care. Read Dr. Cannon’s profile. Many patients that are receiving chemotherapy ask…

Read More

Folic Acid Fortification: Is it a Great Idea?

Kate Burdekin is a clinical research associate with Inova Dwight and Martha Schar Cancer Institute. She coordinates the administrative and regulatory aspects of clinical trials. Kate has a BS in neurobiology and physiology from University of Maryland. She is currently working to complete a master’s degree in public health with a concentration in epidemiology and biostatistics from University…

Read More